|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03886 TOWN HEALTH
Nominal 
0.177 -0.004 (-2.210%) | 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Turnover | 876,385 | -2.724% | 1,785,563 | 1,833,795 | 1,833,038 | 1,535,580 |
| Cost of Sales | (649,112) | -3.225% | (1,321,410) | (1,346,406) | (1,331,090) | (1,121,134) |
| Gross Profit | 227,273 | -1.262% | 464,153 | 487,389 | 501,948 | 414,446 |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 6,947 | -4.364% | 19,159 | (7,155) | (5,319) | (14,826) | |
| Profit / (Loss) before Taxation | 52,642 | -0.892% | 104,998 | (121,691) | (120,863) | 82,503 | |
| Taxation | (15,402) | -12.104% | (40,198) | (36,516) | (38,226) | (32,981) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (24,337) | 6.433% | (50,423) | (45,496) | (35,121) | (34,233) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 12,903 | 1.383% | 14,377 | (203,703) | (194,210) | 15,289 | |
| 2026/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | |
| Net Finance Costs / (Income) | (11,086) | 59.672% | (20,928) | (12,664) | (8,284) | (16,809) |
| Depreciation & Amortisation | 59,823 | -9.739% | 131,354 | 136,662 | 145,629 | 127,560 |
| Directors' Emoluments | 7,347 | 7.507% | 13,388 | 11,745 | 16,101 | 12,805 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 0.190 | 0.000% | 0.210 | -3.010 | -2.870 | 0.210 |
| DPS (cts) | 0.000 | -- | 0.180 | 0.120 | 0.120 | 0.120 |
| Dividend Payout Ratio (%) | -- | -- | 85.714% | -- | -- | 57.143% |
| Cash flow per share ($) | -- | -- | 0.022 | 0.036 | 0.037 | 0.006 |
| NBV per share ($) | 0.448 | -- | 0.443 | 0.439 | 0.479 | 0.511 |
| Remarks: | Real time quote last updated: 10/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 12,903 |
| %Change | 1.383% |
| EPS / (LPS) | HKD 0.002 |
| NBV Per Share ($) | HKD 0.448 |